Ji Won Lee Selected Research

Fever (Fevers)

10/2020	Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
8/2015	Heterotopic ossification in a tetraplegic patient with prolonged fever.
7/2015	Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji Won Lee Research Topics

Disease

51	Neoplasms (Cancer) 03/2024 - 07/2007
17	Neuroblastoma 03/2024 - 10/2016
12	Infections 10/2022 - 11/2010
9	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2008
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2021 - 10/2014
6	Inflammation (Inflammations) 04/2024 - 01/2012
6	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2013
6	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2008
6	Insulin Resistance 11/2017 - 01/2012
5	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 12/2008
5	Neutropenia 01/2022 - 10/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2013
4	Alopecia (Baldness) 01/2024 - 03/2014
4	Leukemia 05/2021 - 03/2015
3	Thrombosis (Thrombus) 10/2023 - 06/2012
3	Obesity 07/2023 - 01/2013
3	Germinoma 01/2023 - 11/2020
3	Chest Pain (Chest Pains) 10/2021 - 09/2012
3	Lymphoma (Lymphomas) 11/2020 - 11/2012
3	Fever (Fevers) 10/2020 - 07/2015
3	Adenocarcinoma 02/2020 - 12/2011
3	Medulloblastoma 01/2020 - 10/2013
3	Hemorrhage 01/2020 - 02/2017
3	Retinoblastoma (Glioblastoma, Retinal) 05/2015 - 12/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2013
2	Lung Neoplasms (Lung Cancer) 01/2024 - 07/2020
2	Hip Osteoarthritis (Coxarthrosis) 11/2023 - 07/2023
2	Myocardial Infarction 10/2023 - 06/2016
2	Sepsis (Septicemia) 07/2023 - 02/2022
2	Hypertension (High Blood Pressure) 07/2023 - 03/2022
2	Residual Neoplasm 11/2022 - 10/2019
2	Body Weight (Weight, Body) 04/2022 - 01/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2022 - 03/2015
2	Cytomegalovirus Infections (Inclusion Disease) 02/2022 - 08/2009
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2012
2	Brain Neoplasms (Brain Tumor) 12/2020 - 10/2013
2	Febrile Neutropenia 10/2020 - 01/2015
2	Margins of Excision 01/2020 - 08/2019
2	Pneumothorax 08/2018 - 02/2017
2	Hematologic Neoplasms (Hematological Malignancy) 06/2018 - 01/2018
2	Blindness (Hysterical Blindness) 01/2017 - 01/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016 - 06/2010
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2016 - 08/2009

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	CytokinesIBA 12/2022 - 12/2021
5	CalciumIBA 10/2021 - 09/2012
5	AdiponectinIBA 11/2017 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 10/2013
4	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2018
4	LigandsIBA 01/2022 - 01/2017
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021 - 10/2013
4	fludarabineIBA 05/2021 - 01/2015
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 06/2011
4	Insulin (Novolin)FDA Link 11/2017 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2024 - 10/2016
3	Minoxidil (Rogaine)FDA LinkGeneric 01/2024 - 01/2023
3	Immune Checkpoint InhibitorsIBA 12/2022 - 04/2021
3	CreatinineIBA 03/2022 - 01/2013
3	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022 - 01/2017
3	2-mercaptopurineIBA 03/2021 - 07/2018
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2013
3	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 10/2013
2	Peptides (Polypeptides)IBA 12/2022 - 04/2021
2	VaccinesIBA 12/2022 - 04/2021
2	InterferonsIBA 12/2022 - 12/2021
2	B7-H1 AntigenIBA 12/2022 - 12/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2021
2	LipidsIBA 01/2022 - 01/2012
2	AntigensIBA 12/2021 - 04/2021
2	Vanilmandelic Acid (Vanillylmandelic Acid)IBA 06/2021 - 10/2018
2	CholesterolIBA 04/2021 - 10/2013
2	Thioguanine (Tioguanine)FDA Link 03/2021 - 01/2021
2	SteroidsIBA 02/2021 - 11/2020
2	PolyaminesIBA 02/2021 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 09/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2020 - 10/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2019
2	Ethiodized Oil (Ethiodol)FDA Link 01/2020 - 02/2017
2	Busulfan (Busulfex)FDA Link 11/2016 - 01/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016 - 03/2015
2	Itraconazole (Sporanox)FDA LinkGeneric 07/2015 - 01/2015

Therapy/Procedure

38	Drug Therapy (Chemotherapy) 04/2024 - 07/2007
32	Therapeutics 04/2024 - 07/2007
15	Stem Cell Transplantation 03/2024 - 12/2008
8	Hematopoietic Stem Cell Transplantation 03/2023 - 08/2009
8	Radiotherapy 12/2022 - 12/2008
6	Transplantation 02/2022 - 08/2009
5	Immunotherapy 12/2022 - 01/2018
3	Aftercare (After-Treatment) 10/2023 - 05/2015
2	Induction Chemotherapy 03/2024 - 11/2020
2	Percutaneous Coronary Intervention 10/2023 - 06/2016
2	Reoperation 07/2023 - 10/2022
2	Cell Transplantation 01/2023 - 01/2020
2	Adjuvant Chemotherapy 01/2023 - 02/2020
2	Neoadjuvant Therapy 01/2022 - 12/2008
2	Combined Modality Therapy 12/2020 - 01/2018
2	Craniospinal Irradiation 12/2020 - 08/2017
2	Length of Stay 08/2019 - 05/2013
2	Salvage Therapy 10/2018 - 10/2013